| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/22/1999 | CA2307328A1 Cell division regulators |
| 04/22/1999 | CA2306455A1 Human receptor proteins; related reagents and methods |
| 04/22/1999 | CA2306453A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 04/22/1999 | CA2306448A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 04/22/1999 | CA2306420A1 Iso-cbi and iso-ci analogs of cc-1065 and the duocarmycins |
| 04/22/1999 | CA2306276A1 Pharmaceutically active compound and methods of use |
| 04/22/1999 | CA2306096A1 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 04/22/1999 | CA2306076A1 Combinatorial preparation of phosphinic acid derivatives |
| 04/22/1999 | CA2306062A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 04/22/1999 | CA2305690A1 53 human secreted proteins |
| 04/22/1999 | CA2305614A1 Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids |
| 04/22/1999 | CA2305353A1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof |
| 04/22/1999 | CA2305180A1 Ih-modulators |
| 04/22/1999 | CA2304473A1 Inhibitors of farnesyl protein transferase |
| 04/22/1999 | CA2304379A1 Benzimidazole compounds, pharmaceutical compositions containing the compounds and their use |
| 04/22/1999 | CA2275135A1 Phosphodiesterase 8a |
| 04/21/1999 | EP0909758A1 Dithiolylidene acetamide derivatives |
| 04/21/1999 | EP0909564A1 Erythropoietin solution preparation |
| 04/21/1999 | EP0909560A2 Treatment o tumors with compounds having RXR retinoid receptor agoinst activity |
| 04/21/1999 | EP0909557A1 Use of honey as an agent for decreasing micro-organisms adhesion |
| 04/21/1999 | EP0909556A1 Rosaceae extract as bradykinin antagonist |
| 04/21/1999 | EP0909184A2 Targeted drug delivery using sulfonamide derivatives |
| 04/21/1999 | EP0909178A1 Interleukin-8 as an antiviral and antitumor agent |
| 04/21/1999 | EP0909177A1 Aqueous formulations of peptides |
| 04/21/1999 | EP0909175A1 Non-aqueous protic peptide formulations |
| 04/21/1999 | EP0909174A1 TREATMENT OF CYSTIC DISEASE WITH TNF-$g(a) |
| 04/21/1999 | EP0909171A1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 04/21/1999 | EP0909169A1 Medical use |
| 04/21/1999 | EP0909132A1 Dietetic foods containing conjugated linoleic acids |
| 04/21/1999 | EP0885217A4 Endothelin receptor antagonists |
| 04/21/1999 | EP0882039A4 Endothelin receptor antagonists |
| 04/21/1999 | EP0793641B1 Metalloproteinase inhibitors |
| 04/21/1999 | EP0743938B1 Substituted spiro compounds for the treatment of inflammation |
| 04/21/1999 | EP0717731B1 Difluoro statone antiviral analogs |
| 04/21/1999 | EP0712397B1 Amide derivatives as 5ht1d receptor antagonists |
| 04/21/1999 | EP0633261B1 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 04/21/1999 | CN1214733A Down-regualtion resistant C3 convertase |
| 04/21/1999 | CN1214695A ErdB3 antibodies |
| 04/21/1999 | CN1214694A Peptides with antiproliferative properties |
| 04/21/1999 | CN1214690A Specific immunophilin ligands as antiasthmatics and immunosuppressants |
| 04/21/1999 | CN1214689A Method of producing IGF-I and IGFBP-3 with correct folding and disulfide bonding |
| 04/21/1999 | CN1214685A Inhibitors of farnesyl protein transferase |
| 04/21/1999 | CN1214682A Eprosartan dihydrate and process for its production and formulation |
| 04/21/1999 | CN1214677A Diphenyl stilbenes as prodrugs to cox-2 inhibitors |
| 04/21/1999 | CN1214675A Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 04/21/1999 | CN1214672A Dimethyl-substituted cyclohexane diene derivatives |
| 04/21/1999 | CN1214631A Use of rapamycin derivatives in vasculopathies and xenotransplantation |
| 04/21/1999 | CN1214629A Solid instant-release forms of administration and process for producing the same |
| 04/21/1999 | CN1214624A Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins |
| 04/21/1999 | CN1214339A Pyrazole derivatives, their preparation and their use in pharmaceuticals |
| 04/21/1999 | CN1214260A Nutritious health care medicine |
| 04/21/1999 | CA2251266A1 Beta-ketoester |
| 04/20/1999 | CA2250664A1 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals |
| 04/20/1999 | CA2250627A1 Manufacture of a lycopene metabolite |
| 04/20/1999 | CA2124990C Pharmaceutical agents for treatment of emesis |
| 04/17/1999 | CA2250523A1 Dithiolylidene acetamide derivatives |
| 04/15/1999 | WO1999018235A1 Process for detecting, extracting or removing human or mammalian cells with a disturbed cellular cycle regulation or unlimited proliferation or tumour-forming ability |
| 04/15/1999 | WO1999018213A1 MUTANTS OF YEAST Cdc24p, DEFECTIVE IN BINDING OF THE G-PROTEIN BETA SUBUNIT |
| 04/15/1999 | WO1999018208A1 101 human secreted proteins |
| 04/15/1999 | WO1999018191A1 Transgenic animals with knocked-in vec receptor genes and uses thereof |
| 04/15/1999 | WO1999018129A1 Soluble single-chain t-cell receptor proteins |
| 04/15/1999 | WO1999018128A1 Fibroblast growth factor with hepatocyte proliferation activity |
| 04/15/1999 | WO1999018101A1 Benzothiophenes |
| 04/15/1999 | WO1999018099A1 Aryl thiophene derivatives as pde iv inhibitors |
| 04/15/1999 | WO1999018096A1 Inhibitors of prenyl-protein transferase |
| 04/15/1999 | WO1999018095A1 Aryl furan derivatives as pde iv inhibitors |
| 04/15/1999 | WO1999018076A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | WO1999018074A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | WO1999017802A1 Methods and compositions for the selective modification of nucleic acids |
| 04/15/1999 | WO1999017800A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | WO1999017798A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/15/1999 | WO1999017797A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | WO1999017794A1 UDP-N-ACETYLMURAMOYL-L-AIANINE:D-GLUTAMATE LIGASE (murD) OF STAPHYLOCOCCUS AUREUS |
| 04/15/1999 | WO1999017790A1 PEPTIDE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 04/15/1999 | WO1999017787A2 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 04/15/1999 | WO1999017784A1 Treating occlusive peripheral vascular disease and coronary disease with combinations of heparin and an adenoside a2 agonist, or with adenosine |
| 04/15/1999 | WO1999017778A1 α-KETOAMIDE MULTICATALYTIC PROTEASE INHIBITORS |
| 04/15/1999 | WO1999017776A1 Novel cycloalkenyl substituted compounds |
| 04/15/1999 | WO1999017775A1 QUINOLINE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 04/15/1999 | WO1999017773A1 Compounds and methods |
| 04/15/1999 | WO1999017772A1 5ht4 agonists and antagonists |
| 04/15/1999 | WO1999017771A1 Granular preparations of 5-(2-ethyl- 2h-tetrazol- 5-yl)-1-methyl-1, 2,3,6-tetrahydropyridine |
| 04/15/1999 | WO1999017770A1 Indeno[1,2-c]pyrazole derivatives for inhibiting tyrosine kinase activity |
| 04/15/1999 | WO1999017769A1 INDENO[1,2-c]-, NAPHTHO[1,2-c]- AND BENZO[6,7]CYCLOHEPTA[1,2-c]PYRAZOLE DERIVATIVES |
| 04/15/1999 | WO1999017765A1 Use of d-methionine to reduce the toxicity of ototoxic drugs, noise, and radiation |
| 04/15/1999 | WO1999017759A2 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 04/15/1999 | WO1999017755A2 Medicaments |
| 04/15/1999 | WO1999017754A1 Dosage form for aerosol administration |
| 04/15/1999 | WO1999017743A1 Dosage forms having improved release properties |
| 04/15/1999 | WO1999017742A2 Taste masked formulations |
| 04/15/1999 | WO1999017741A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | WO1999009025A3 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor |
| 04/15/1999 | WO1999008708A3 Method and food product for increasing muscle protein and reducing fat in animals |
| 04/15/1999 | WO1999008668A3 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 04/15/1999 | WO1999008666A3 Pharmaceutical composition comprising an azateroid |
| 04/15/1999 | WO1999005170A8 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 04/15/1999 | WO1999004773A3 Method for inhibiting bone resorption |
| 04/15/1999 | WO1999004770A3 A pharmaceutical composition active in reducing production of mcp-1 protein |
| 04/15/1999 | WO1999002142A3 Novel composition comprising an ssri and a beta-blocker |
| 04/15/1999 | WO1998055118A3 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases |